Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Siyuan Sun, Zhongjian Chen, Liping Li, Dongli Sun, Ye Tian, Hao Pan, Huichang Bi, Min Huang, Su Zeng & Huidi Jiang. (2012) The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica 42:12, pages 1197-1205.
Read now
Read now
Caroline H. Walker, Barbara A. Drew, James W. Antoon, Alan V. Kalueff & Barbara S. Beckman. (2012) Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives. Cancer Investigation 30:2, pages 135-148.
Read now
Read now
Stephen Drain, Mark A. Catherwood & H. Denis Alexander. (2010) Multidrug resistance in the chronic lymphoproliferative disorders. Leukemia & Lymphoma 51:10, pages 1793-1804.
Read now
Read now
Joel A Lefferts, Claudine L Bartels & Gregory J Tsongalis. (2007) Pharmacogenetics: where are we with respect to personalized medicine?. Expert Opinion on Medical Diagnostics 1:1, pages 117-128.
Read now
Read now
Arcadi Svirnovski, Vadim Pasiukov & Sergei Grigorovich. (2005) Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition. Hematology 10:4, pages 313-319.
Read now
Read now
Suresh Katragadda, Balasubrahmanyam Budda, Banmeet S Anand & Ashim K Mitra. (2005) Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opinion on Drug Delivery 2:4, pages 683-705.
Read now
Read now
Articles from other publishers (57)
Deming Ou, Ying Wu, Jibin Zhang, Jun Liu, Zeyu Liu, Minfeng Shao, Xiaoying Guo & Shiman Cui. (2023) MYEOV with High Frequencies of Mutations in Head and Neck Cancers Facilitates Cancer Cell Malignant Behaviors. Biochemical Genetics.
Crossref
Crossref
Elizabeth A. Hughes, Rafał Zieliński, Ashley E. Ray, Waldemar Priebe & Eugene F. Douglass Junior. (2023) Development of a Novel Tool To Demystify Drug Distribution at Tissue‐Blood Barriers. ChemBioChem 24:13.
Crossref
Crossref
Ekin Guran, Jian Hu, Jeffrey S. Wefel, Caroline Chung & Juan P. Cata. (2022) Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. British Journal of Anaesthesia 129:6, pages 909-922.
Crossref
Crossref
Gilbert Youssef, Patrick Y. Wen & Eudocia Q. Lee. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
479
500
.
Kellen Gandy, Matthew A Scoggins, Lisa M Jacola, Molly Litten, Wilburn E Reddick & Kevin R Krull. (2021) Structural and Functional Brain Imaging in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Treated With Chemotherapy: A Systematic Review. JNCI Cancer Spectrum 5:5.
Crossref
Crossref
Mohd Aleem, Deepti Sharma, Deepshikha Sharma, Siddhartha Dan, Pooja Gupta, Khalid Umar Fakhri & M. Moshahid Alam Rizvi. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics
312
338
.
Shahid M. Baba, Arshad A. Pandith, Zafar A. Shah, Sajad A. Geelani, Mohammad Muzaffar Mir, Javid Rasool Bhat & Gul Mohammad Bhat. (2020) Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case–Control Study. Indian Journal of Hematology and Blood Transfusion 37:1, pages 21-29.
Crossref
Crossref
Robert D. Nerenz. 2018. Molecular Pathology. Molecular Pathology
731
743
.
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Ke Yang, Yifan Chen, Kenneth Kin Wah To, Fang Wang, Delan Li, Likun Chen & Liwu Fu. (2017) Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Experimental & Molecular Medicine 49:3, pages e303-e303.
Crossref
Crossref
Marta Hegyi, Adam Arany, Agnes F. Semsei, Katalin Csordas, Oliver Eipel, Andras Gezsi, Nora Kutszegi, Monika Csoka, Judit Muller, Daniel J. Erdelyi, Peter Antal, Csaba Szalai & Gabor T. Kovacs. (2016) Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. Oncotarget 8:6, pages 9388-9398.
Crossref
Crossref
Guangmin Xi, Ming Wang, Bing Sun, Abdul Sami Shaikh, Yongqing Liu, Wei Wang, Hongxiang Lou & Huiqing Yuan. (2016) Targeting autophagy augments the activity of DHA-E3 to overcome p-gp mediated multi-drug resistance. Biomedicine & Pharmacotherapy 84, pages 1610-1616.
Crossref
Crossref
Zhen Chen, Yifan Chen, Meng Xu, Likun Chen, Xu Zhang, Kenneth Kin Wah To, Hongyun Zhao, Fang Wang, Zhongjun Xia, Xiaoqin Chen & Liwu Fu. (2016)
Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells
In Vitro, In Vivo
, and
Ex Vivo
. Molecular Cancer Therapeutics 15:8, pages 1845-1858.
Crossref
Crossref
R. R. Panchuk, L. V. Lehka, J. Rohr, W. Berger & R. S. Stoika. (2016) Mitochondria do not play a major role in landomycin E-induced ROS burst and circumvention of multiple drug resistance in HL-60 leukemia cells. Biopolymers and Cell 32:3, pages 190-202.
Crossref
Crossref
Sam V. Kaplan, Ryan A. Limbocker, Rachel C. Gehringer, Jenny L. Divis, Gregory L. Osterhaus, Maxwell D. Newby, Michael J. Sofis, David P. Jarmolowicz, Brooke D. Newman, Tiffany A. Mathews & Michael A. Johnson. (2016) Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin. ACS Chemical Neuroscience 7:6, pages 689-699.
Crossref
Crossref
Shizhu Chen, Keni Yang, Ruslan G. Tuguntaev, Anbu Mozhi, Jinchao Zhang, Paul C. Wang & Xing-Jie Liang. (2016) Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine: Nanotechnology, Biology and Medicine 12:2, pages 269-286.
Crossref
Crossref
Wanida Pongstaporn, Samart Pakakasama, Panee Chaksangchaichote, Tanett Pongtheerat, Suradej Hongeng & Songsak Permitr. (2015) MDR1 C3435T and C1236T Polymorphisms: Association with High-risk Childhood Acute Lymphoblastic Leukemia. Asian Pacific Journal of Cancer Prevention 16:7, pages 2839-2843.
Crossref
Crossref
Mabel LardoMarcelo CastroBeatriz MoiraghiFrancisca RojasNatalia BordaJorge A ReyAlberto Lazarowski. (2015)
MDR1/ABCB1
gene polymorphisms in patients with chronic myeloid leukemia
. Blood Research 50:3, pages 154.
Crossref
Crossref
Shereen Mohamed El-hoseiny, Khaled El-Sayed Elhadidy, Soraya Mohamed Ahmed & Ahmed Mahmoud Khallaf. (2013) The role of MDR1 (C3435T) gene polymorphism in Egyptian acute lymphoblastic leukemia. Comparative Clinical Pathology 24:1, pages 79-88.
Crossref
Crossref
Sithambaram Devilakshmi, Jayaprakasam Madhumathi & Rama Shanker Verma. 2015. Resistance to Immunotoxins in Cancer Therapy. Resistance to Immunotoxins in Cancer Therapy
33
56
.
Chen Yan, Li Huang, Hong-Chun Liu, Duo-Zhi Chen, Hai-Yang Liu, Xiao-Hui Li, Yu Zhang, Mei-Yu Geng, Quan Chen & Xiao-Jiang Hao. (2014) Spiramine derivatives induce apoptosis of Bax−/−/Bak−/− cell and cancer cells. Bioorganic & Medicinal Chemistry Letters 24:8, pages 1884-1888.
Crossref
Crossref
Saher K. Elden Hussien, Asmaa Ahmed Abdel-Aal, Reham A. Aleem Afify & Noha El-Husseiny. (2012) MDR1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia. Comparative Clinical Pathology 23:1, pages 119-124.
Crossref
Crossref
Jeanne S. Mandelblatt, Arti Hurria, Brenna C. McDonald, Andrew J. Saykin, Robert A. Stern, John W. VanMeter, Meghan McGuckin, Tiffani Traina, Neelima Denduluri, Scott Turner, Darlene Howard, Paul B. Jacobsen & Tim Ahles. (2013) Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?. Seminars in Oncology 40:6, pages 709-725.
Crossref
Crossref
Dan He, Xiao-qin Zhao, Xing-gui Chen, Yi Fang, Satyakam Singh, Tanaji T. Talele, Hui-juan Qiu, Yong-ju Liang, Xiao-kun Wang, Guo-qing Zhang, Zhe-sheng Chen & Li-wu Fu. (2013) BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells. PLoS ONE 8:1, pages e54181.
Crossref
Crossref
Svatopluk Světlík, Karolína Hronová, Hana Bakhouche, Olga Matoušková & Ondřej Slanař. (2013) Pharmacogenetics of Chronic Pain and Its Treatment. Mediators of Inflammation 2013, pages 1-23.
Crossref
Crossref
Athanasios I. Zavras & Angela J. Yoon. 2013. Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Head & Neck Cancer: Current Perspectives, Advances, and Challenges
977
1002
.
Makrem Ben Reguiga, Celine Bouquet, Robert Farinotti & Laurence Bonhomme-Faivre. (2012) Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice. Life Sciences 91:17-18, pages 843-851.
Crossref
Crossref
Daniele Campa, Katja Butterbach, Susan L. Slager, Christine F. Skibola, Silvia de Sanjosé, Yolanda Benavente, Nikolaus Becker, Lenka Foretova, Marc Maynadie, Pierluigi Cocco, Anthony Staines, Rudolf Kaaks, Paolo Boffetta, Paul Brennan, Lucia Conde, Paige M. Bracci, Neil E. Caporaso, Sara S. Strom, Nicola J. Camp, James R. Cerhan, GEC Consortium, Federico Canzian & Alexandra Nieters. (2011)
A comprehensive study of polymorphisms in the
ABCB1
,
ABCC2
,
ABCG2
,
NR1I2
genes and lymphoma risk
. International Journal of Cancer 131:4, pages 803-812.
Crossref
Crossref
G. Penna, A. Allegra, A. Alonci, M. Aguennouz, A. Garufi, A. Cannavò, D. Gerace, A. Alibrandi & C. Musolino. (2010) MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. Medical Oncology 28:4, pages 1549-1554.
Crossref
Crossref
Chin-Chuan Hung & Horng-Huei Liou. (2010) YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway. Investigational New Drugs 29:6, pages 1337-1346.
Crossref
Crossref
Alan HB WuJaekyu Shin. (2011) Research Highlights. Personalized Medicine 8:6, pages 611-613.
Crossref
Crossref
Lara Milane, Shanthi Ganesh, Shruti Shah, Zhen-feng Duan & Mansoor Amiji. (2011) Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology. Journal of Controlled Release 155:2, pages 237-247.
Crossref
Crossref
Lara Milane, Zhen-feng Duan & Mansoor Amiji. (2011) Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine 7:4, pages 435-444.
Crossref
Crossref
Pei-Rong Ding, Amit K. Tiwari, Shinobu Ohnuma, Jeferson W. K. K. Lee, Xin An, Chun-Ling Dai, Qi-Si Lu, Satyakam Singh, Dong-Hua Yang, Tanaji T. Talele, Suresh V. Ambudkar & Zhe-Sheng Chen. (2011) The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter. PLoS ONE 6:4, pages e19329.
Crossref
Crossref
Lara Milane, Zhenfeng Duan & Mansoor Amiji. (2010) Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells. Molecular Pharmaceutics 8:1, pages 185-203.
Crossref
Crossref
Kosuke Narumiya, Ralf Metzger, Elfriede Bollschweiler, Hakan Alakus, Jan Brabender, Uta Drebber, Arnulf H Hölscher & Ute Warnecke-Eberz. (2011)
Impact of
ABCB1
C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer
. Pharmacogenomics 12:2, pages 205-214.
Crossref
Crossref
Cheng-jun Shi, Fang Wang, Mei-feng Ren, Yan-jun Mi, Yan-yan Yan, Kenneth Kin Wah To, Chun-ling Dai, Yan-sheng Wang, Li-ming Chen, Xiu-zhen Tong, Yong-ju Liang & Li-wu Fu. (2011) Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation. Leukemia Research 35:1, pages 73-79.
Crossref
Crossref
William C. Kreisl, Jeih-San Liow, Nobuyo Kimura, Nicholas Seneca, Sami S. Zoghbi, Cheryl L. Morse, Peter Herscovitch, Victor W. Pike & Robert B. Innis. (2010)
P-Glycoprotein Function at the Blood–Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer
11
C-
N-Desmethyl
-Loperamide
. Journal of Nuclear Medicine 51:4, pages 559-566.
Crossref
Crossref
Melissa A SmithAnthony M Marinaki & Jeremy D Sanderson. (2010) Pharmacogenomics in the treatment of inflammatory bowel disease. Pharmacogenomics 11:3, pages 421-437.
Crossref
Crossref
Allen Eng-Juh Yeoh, Yi Lu, Jason Yong-Sheng Chan, Yiong Huak Chan, Hany Ariffin, Shirley Kow-Yin Kham & Thuan Chong Quah. (2010) Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group. Leukemia Research 34:3, pages 276-283.
Crossref
Crossref
Hong Kee Lee & Gregory J. Tsongalis. 2010. Essential Concepts in Molecular Pathology. Essential Concepts in Molecular Pathology
421
428
.
Sevtap Savas & Geoffrey Liu. (2009) Genetic variations as cancer prognostic markers: review and update. Human Mutation 30:10, pages 1369-1377.
Crossref
Crossref
Chun-ling Dai, Yong-ju Liang, Li-ming Chen, Xu Zhang, Wen-jing Deng, Xiao-dong Su, Zhi Shi, Chung-pu Wu, Charles R. AshbyJr.Jr., Shin-ichi Akiyama, Suresh V. Ambudkar, Zhe-sheng Chen & Li-wu Fu. (2009) Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Biochemical Pharmacology 78:4, pages 355-364.
Crossref
Crossref
Hong Kee Lee & Gregory J. Tsongalis. 2009. Molecular Pathology. Molecular Pathology
613
622
.
Janette Vardy. 2009. Adjuvant Therapy for Breast Cancer. Adjuvant Therapy for Breast Cancer
387
419
.
Steven S. Carey, Mary Gleason-Guzman, Vijay Gokhale & Laurence H. Hurley. (2008) Psorospermin structural requirements for P-glycoprotein resistance reversal. Molecular Cancer Therapeutics 7:11, pages 3617-3623.
Crossref
Crossref
Lara Jabr-Milane, Lilian van Vlerken, Harikrishna Devalapally, Dinesh Shenoy, Sushma Komareddy, Mayank Bhavsar & Mansoor Amiji. (2008) Multi-functional nanocarriers for targeted delivery of drugs and genes. Journal of Controlled Release 130:2, pages 121-128.
Crossref
Crossref
Ágnes F. Semsei, Dániel J. Erdélyi, Ildikó Ungvári, Enikő Kámory, Béla Csókay, Hajnalka Andrikovics, Attila Tordai, Edit Cságoly, András Falus, Gábor T. Kovács & Csaba Szalai. (2008) Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leukemia Research 32:8, pages 1214-1220.
Crossref
Crossref
Stuart S. Winter, Debbie M. Lovato, Hadya M. Khawaja, Bruce S. Edwards, Irena D. Steele, Susan M. Young, Tudor I. Oprea, Larry A. Sklar & Richard S. Larson. (2008) High-Throughput Screening for Daunorubicin-Mediated Drug Resistance Identifies Mometasone Furoate as a Novel ABCB1-Reversal Agent. SLAS Discovery 13:3, pages 185-193.
Crossref
Crossref
Jessica Hopkins, David W. Cescon, Darren Tse, Penelope Bradbury, Wei Xu, Clement Ma, Paul Wheatley-Price, John Waldron, David Goldstein, Francois Meyer, Isabelle Bairati & Geoffrey Liu. (2008) Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review. Cancer Epidemiology, Biomarkers & Prevention 17:3, pages 490-499.
Crossref
Crossref
Stuart S. WinterZeyu Jiang, Hadya M. KhawajaTimothy GriffinMeenakshi DevidasBarbara L. Asselin & Richard S. Larson. (2007) Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 110:5, pages 1429-1438.
Crossref
Crossref
Serena Marchetti, Roberto Mazzanti, Jos H. Beijnen & Jan H. M. Schellens. (2007) Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein). The Oncologist 12:8, pages 927-941.
Crossref
Crossref
Carsten Kneuer, Walther Honscha, Gotthold Gäbel & Kerstin U. Honscha. (2007) Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells. Pflügers Archiv - European Journal of Physiology 454:4, pages 587-594.
Crossref
Crossref
Tim A. Ahles & Andrew J. Saykin. (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer 7:3, pages 192-201.
Crossref
Crossref
Cassandra EI Szoeke, Mark Newton, Julie M Wood, David Goldstein, Samuel F Berkovic, Terrence J OBrien & Les J Sheffield. (2006) Update on pharmacogenetics in epilepsy: a brief review. The Lancet Neurology 5:2, pages 189-196.
Crossref
Crossref
Yan-Hong LI, Yong-Hua WANG, Yan LI & Ling YANG. (2006) MDR1 Gene Polymorphisms and Clinical Relevance. Acta Genetica Sinica 33:2, pages 93-104.
Crossref
Crossref
Erin R Lepper, Kees Nooter, Jaap Verweij, Milin R Acharya, William D Figg & Alex Sparreboom. (2005) Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics 6:2, pages 115-138.
Crossref
Crossref